New hope for Tough-to-Treat lung cancer?
Disease control
Terminated
This study tested a new drug called hSTC810 combined with a standard chemotherapy (paclitaxel) for people with advanced small cell lung cancer that had returned or stopped responding to prior treatment. The goal was to see if this combination was safe and could help control the c…
Phase: PHASE1, PHASE2 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC